While clinical research has always been multifaceted, clinical trial complexity levels continue to grow. Protocols now include significantly more endpoints, procedures, and data points than in the past. Despite advances in biomarkers, innovative study designs, and technology support, site staff report high workloads and persistent operational burdens. Supporting site teams, who must navigate increasingly intricate protocols and a proliferation of digital systems, often with limited time and resources, is essential. This article helps deepen our understanding of these challenges to deliver solutions that are both practical and truly actionable.
The challenges that have a significant impact on site burden
While site staff face numerous challenges every day, three particularly significant constraints have not been sufficiently addressed so far.
The growing complexity of study protocols
Analyses show that protocol complexity has increased dramatically over the last two decades, with corresponding increases in site effort and operational strain.
This rising complexity has an immediate and profound impact on site teams, who must manage stricter inclusion and exclusion criteria, a higher number of procedures at each visit, increased volumes of data collection and reporting, and greater coordination requirements across team members, workflows, systems, and equipment.
Protocols in oncology, neurology, or cardiology that include extensive imaging procedures may require several patient transfers per visit, depending on the schedule of assessments, which further increases site burden.
The pressure on study timelines and resources
In parallel, trial timelines have lengthened and success rates remain stubbornly low.
Starting a clinical trial remains a very long and resource-intensive process. Setup timelines are difficult to reduce—despite sponsor pressure—and increasingly complex site budgets and contract negotiations can have a negative impact on site activation.
Recruiting and retaining qualified site staff remains a major bottleneck, and 30% of sites listed staffing shortages as a top challenge in a 2025 report. The Society for Clinical Research Sites (SCRS) emphasizes that rising personnel costs, a scarcity of skilled staff, and sustained increases in workload lead to delays in patient visits and data entry, increased burnout and turnover, and a reduced capacity for sites to take on new studies.
The rising number of digital systems
As well as complex protocol design and multiple procedures, today’s clinical trial landscape requires sites to operate an increasing number of digital systems for a single study.
Once a patient’s inclusion has been confirmed against the numerous inclusion and exclusion criteria, a study coordinator may randomize the patient in an IRT system, then log into a separate eCOA platform to activate questionnaires, manually re‑enter patient identifiers, confirm visit dates, and later cross‑check that dosing, compliance, and participant status are aligned across a range of tools. Sites may also need to use electronic Case Report Forms (eCRFs) as well as safety reporting systems and study management tools, and a typical oncology study may require sites to use up to 17 disconnected systems.
While each system addresses a specific need, their coexistence often results in fragmented workflows, multiple logins, duplicate data entry, and complex reconciliation processes, increasing the risk of delays, errors, and frustration. This fragmented digital experience adds a significant administrative workload to already overstretched site teams, turning system management into a daily task rather than a background process.
As a result, sites increasingly expect integrated solutions that reduce duplicate actions, provide a single operational view of the study, and allow staff to focus on their patients rather than systems.
Where integration makes a difference for site teams
Trial designs often overlook the impact on patients and the investigator burden, which becomes increasingly problematic as clinical trial complexity continues to rise. Supporting sites in facing this complexity and proposing options to mitigate their challenges has become an absolute necessity.
Reducing the burden of those who must use technology daily will not be possible without combined effort to deliver integrated solutions.
Estelle Haenel
Chief Medical Officer at Kayentis
“While integration may not always be technically possible or may not be appropriate in all cases, some system integrations will have an immediate and measurable benefit for site staff.”
As an example, integrating eCOA and IRT into a single, coordinated experience reduces system fragmentation for site staff and immediately results in simplified workflows, fewer manual reconciliations, and more consistent processes across trial activities.
eCOA–IRT integration: a concrete first step
With a unified eCOA–IRT environment, sites benefit from streamlined access to both solutions, clearer workflows with fewer redundant data entries, reduced data management, and a lower query burden. This integration ensures that the right data are available at the right time across systems, supporting accurate trial conduct, patient status follow-up, and clinical site decision-making processes.
When designed to support all study types, across therapeutic areas and levels of complexity, the same eCOA and IRT integrated systems can be implemented in multiple trials, preventing the sites needing to switch systems each time they start a new study.
When integrated solutions remain user-friendly and globally scalable, only a limited amount of training is needed together with a quick familiarization process, which also helps to reduce the burden associated with system adoption.
As clinical trial complexity continues to rise, studies are becoming extremely challenging for investigators and site staff. The need to collectively reduce their burden is no longer a matter of debate. Offering frictionless platform interoperability directly alleviates this burden, enabling staff to focus their attention back on patient care rather than system management. Actively reducing technology-driven workloads promotes stronger site engagement, smoother study conduct, and more reliable data collection – benefits that ultimately enhance trial performance and outcomes for all stakeholders.




